|
|
Blood, 8 January 2009, Vol. 113, No. 2, pp. 389-395.
Prepublished online as a Blood First Edition Paper on September 24, 2008; DOI 10.1182/blood-2008-04-153346.
Previous Article | Table of Contents | Next Article 
IMMUNOBIOLOGY
Distinct roles of helper T-cell subsets in a systemic autoimmune disease
Katrina K. Hoyer1,
Wilson F. Kuswanto1,
Eugenio Gallo1, and
Abul K. Abbas1
1 Department of Pathology, University of California San Francisco
Imbalance of T-helper cell (Th) differentiation and subsequent cytokine dysregulation is implicated in inflammatory and autoimmune diseases. In particular, 2 cytokines produced by different Th cell populations, interferon- (IFN- ) and interleukin-17 (IL-17), have been shown to play a critical role in autoimmunity. We have examined the roles of these cytokines in a mouse model of systemic autoimmunity resulting from the deletion of IL-2 in which autoimmune hemolytic anemia (AIHA) is a prominent feature. We demonstrate that, in IL-2–knockout (KO) BALB/c mice, elimination of the Th1 cytokine, IFN- , delays the development of AIHA. Further, CD4+ T cells from IL-2/IFN- –KO mice produce elevated levels of IL-17 compared with wild-type (WT) and IL-2–KO, and these mice eventually develop intestinal inflammation. In contrast, elimination of the Th17 cytokine, IL-17, from IL-2–KO mice fails to suppress early acute AIHA development. These results suggest that in a systemic autoimmune disease with multiple manifestations, Th1 cells drive the early autoantibody response and IL-17–producing cells may be responsible for the more chronic tissue inflammation.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
G. Shi, M. Ramaswamy, B. P. Vistica, C. A. Cox, C. Tan, E. F. Wawrousek, R. M. Siegel, and I. Gery
Unlike Th1, Th17 Cells Mediate Sustained Autoimmune Inflammation and Are Highly Resistant to Restimulation-Induced Cell Death
J. Immunol.,
December 1, 2009;
183(11):
7547 - 7556.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Zuber, A. Brodin-Sartorius, N. Lapidus, N. Patey, M. Tosolini, S. Candon, M. Rabant, R. Snanoudj, C. Panterne, E. Thervet, et al.
FOXP3-enriched infiltrates associated with better outcome in renal allografts with inflamed fibrosis
Nephrol. Dial. Transplant.,
September 3, 2009;
(2009)
gfp435v1.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|